SBC Medical (SBC) said Wednesday it filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $50 million of common or preferred stock from time to time.
Additionally, the company stated that its board has approved a share repurchase program of up to $20 million, which is set to terminate on December 31, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.